NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks.
Last week, Genmab and Zealand Pharma received new price targets, Ascendis Pharma got approval in the U.K. for YORVIPATH/TransCon, the cannabis healthcare company CS Medica announced a partnership with a distributor for Germany and the Gulf, and Expres2ion got MSEK 22.5 in dividend payments strengthening their cash position. The best stock of the week rose 88%.
9 of the 21 Danish companies had a positive share price development the past week and 9 companies have had a positive share price performance year-to-date. Gubra is now the best-performing Danish healthcare stock year-to-date with a 126% return and cannabis company DanCann Pharma was the best Nordic healthcare investment last week.
Stay tuned to the developments of impact companies and stocks in the Nordics with the NORDIC | IMPACT newsletter that helps you invest more sustainably in the businesses of tomorrow.
DANISH COMPANY NEWS